Global Filgrastim Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Lyophilized Powder
Others
Segment by Application
Solid Tumor
Lymphoma
Kidney Cancer
Lung Disease
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Amgen
SANDOZ INC
Teva

Table of Content
1 Filgrastim Market Overview
1.1 Product Overview and Scope of Filgrastim
1.2 Filgrastim Segment by Type
1.2.1 Global Filgrastim Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Lyophilized Powder
1.2.3 Others
1.3 Filgrastim Segment by Application
1.3.1 Global Filgrastim Sales Comparison by Application: (2021-2027)
1.3.2 Solid Tumor
1.3.3 Lymphoma
1.3.4 Kidney Cancer
1.3.5 Lung Disease
1.3.6 Others
1.4 Global Filgrastim Market Size Estimates and Forecasts
1.4.1 Global Filgrastim Revenue 2016-2027
1.4.2 Global Filgrastim Sales 2016-2027
1.4.3 Filgrastim Market Size by Region: 2016 Versus 2021 Versus 2027
2 Filgrastim Market Competition by Manufacturers
2.1 Global Filgrastim Sales Market Share by Manufacturers (2016-2021)
2.2 Global Filgrastim Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Filgrastim Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Filgrastim Manufacturing Sites, Area Served, Product Type
2.5 Filgrastim Market Competitive Situation and Trends
2.5.1 Filgrastim Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Filgrastim Players Market Share by Revenue
2.5.3 Global Filgrastim Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Filgrastim Retrospective Market Scenario by Region
3.1 Global Filgrastim Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Filgrastim Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Filgrastim Market Facts & Figures by Country
3.3.1 North America Filgrastim Sales by Country
3.3.2 North America Filgrastim Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Filgrastim Market Facts & Figures by Country
3.4.1 Europe Filgrastim Sales by Country
3.4.2 Europe Filgrastim Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Filgrastim Market Facts & Figures by Region
3.5.1 Asia Pacific Filgrastim Sales by Region
3.5.2 Asia Pacific Filgrastim Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Filgrastim Market Facts & Figures by Country
3.6.1 Latin America Filgrastim Sales by Country
3.6.2 Latin America Filgrastim Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Filgrastim Market Facts & Figures by Country
3.7.1 Middle East and Africa Filgrastim Sales by Country
3.7.2 Middle East and Africa Filgrastim Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Filgrastim Historic Market Analysis by Type
4.1 Global Filgrastim Sales Market Share by Type (2016-2021)
4.2 Global Filgrastim Revenue Market Share by Type (2016-2021)
4.3 Global Filgrastim Price by Type (2016-2021)
5 Global Filgrastim Historic Market Analysis by Application
5.1 Global Filgrastim Sales Market Share by Application (2016-2021)
5.2 Global Filgrastim Revenue Market Share by Application (2016-2021)
5.3 Global Filgrastim Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Filgrastim Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Amgen Filgrastim Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 SANDOZ INC
6.2.1 SANDOZ INC Corporation Information
6.2.2 SANDOZ INC Description and Business Overview
6.2.3 SANDOZ INC Filgrastim Sales, Revenue and Gross Margin (2016-2021)
6.2.4 SANDOZ INC Filgrastim Product Portfolio
6.2.5 SANDOZ INC Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Filgrastim Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Teva Filgrastim Product Portfolio
6.3.5 Teva Recent Developments/Updates
7 Filgrastim Manufacturing Cost Analysis
7.1 Filgrastim Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Filgrastim
7.4 Filgrastim Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Filgrastim Distributors List
8.3 Filgrastim Customers
9 Filgrastim Market Dynamics
9.1 Filgrastim Industry Trends
9.2 Filgrastim Growth Drivers
9.3 Filgrastim Market Challenges
9.4 Filgrastim Market Restraints
10 Global Market Forecast
10.1 Filgrastim Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Filgrastim by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Filgrastim by Type (2022-2027)
10.2 Filgrastim Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Filgrastim by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Filgrastim by Application (2022-2027)
10.3 Filgrastim Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Filgrastim by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Filgrastim by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer